The IMPAACT Network is closely monitoring the ongoing COVID-19 pandemic. The safety and well-being of IMPAACT study participants, community members, clinical research site staff, and laboratory staff are of utmost importance and the highest priority for our Network. We are tracking all updates and heeding recommendations from national and international health organizations, including the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) regarding the disease.

Consistent with guidance from DAIDS, and in consultation with our NIH partners, action steps are as follows (updated 1 September 2020):

We will continue to provide updates as needed via email and our website. Please stay safe and be well.

Resources and Guidance

Guidance for Re-Opening

General Guidance



Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.